Gabapentin
Product Images NDC 50090-3318

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-3318). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

A formula showing the calculation for creatinine clearance (CLCr), which adjusts for age, weight, sex, and serum creatinine levels, typically used for assessing kidney function in relation to drug dosing.*

FDA Label Image

1 (Image 2)

Gabapentin capsules in a blister pack displayed with a blue and white label indicating A-S Medication Solutions as the labeler. The package is partially visible, showing multiple capsules arranged in rows, but specific dosage strength and count are not legible.*

FDA Label Image

1 (Image 3)

Gabapentin 100 mg capsules in a 90-count bottle from A-S Medication Solutions. The label includes product name, strength, dosage form, quantity, administration instructions, and the labeler's information prominently displayed on the white bottle with an orange cap.*

FDA Label Image

1 (Image 4)

FDA Label Image

1 (Image 5)

Chemical structure of gabapentin molecule showing a cyclohexane ring with attached amino (CH2NH2) and carboxymethyl (CH2CO2H) groups.*

FDA Label Image

1 (Image 6)

Line graph depicting mean pain score over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis shows weeks from baseline to week 8, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain score ranging from 0 to 10. Gabapentin shows a decreasing trend in pain score over time, whereas placebo remains relatively constant.*

FDA Label Image

2 (Image 7)

A line chart showing mean pain score over 7 weeks for placebo and two gabapentin dose groups (1800 mg/day and 2400 mg/day). The X-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The Y-axis shows mean pain score from 0 to 10. Gabapentin groups show a decrease in mean pain score over time compared to placebo.*

FDA Label Image

3 (Image 8)

A bar graph comparing percentages across two studies. The x-axis labels include placebo (PBO) and different dosages of gabapentin (GBP 1800, GBP 2400, GBP 3600). The y-axis represents percentage values from 0% to 100%. The graph indicates statistically significant differences between placebo and gabapentin doses, with significance levels noted as p < 0.01 and p < 0.001.*

FDA Label Image

4 (Image 9)

A scatter plot showing the difference percentage versus daily dose (mg) of Gabapentin across three studies labeled a, b, and c. The x-axis represents daily doses ranging from about 600 mg to 1800 mg, and the y-axis depicts the percentage difference from 2% to 22%. Different symbols and shades identify data points for studies a, b, and c.*

FDA Label Image

Label Image (Lbl500903318)

Label for Gabapentin 300 mg capsules from A-S Medication Solutions. The label includes Product NDC 50090-3318-0 and Product No. 9017-0. It states that each capsule contains 300 mg of gabapentin, storage instructions to keep between 68 to 77 degrees Fahrenheit, and indicates a package size of 33 unit dose capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.